Inogen, Inc. Announces Sale of U.S. Oxygen Rental Assets to Rotech

What Happened

• Inogen, Inc. announced on September 29, 2026 that it entered into an Asset Purchase Agreement with Rotech Healthcare Inc. to sell substantially all assets used or held for use solely in its U.S. oxygen rental business, including specified on-rent and on-hand inventory and related patient records.
• The aggregate purchase price is estimated at up to approximately $24.8 million (subject to post-closing reconciliation) and is payable in six installments. The Transaction is subject to customary closing conditions.
• On September 30, 2026 Inogen issued a press release (furnished as Exhibit 99.1) announcing the Purchase Agreement, a separate product supply agreement with Rotech, and a conditional amendment to its existing share repurchase program.

Key Details

• Buyer: Rotech Healthcare Inc.
• Agreement signed: September 29, 2026; press release issued September 30, 2026.
• Consideration: Estimated up to ~$24.8 million, subject to post-closing reconciliation, payable in six installments.
• Assets sold: Substantially all assets used solely in the operation of Inogen’s U.S. oxygen rental business, including specified on-rent and on-hand inventory and related patient records.

Why It Matters

• This transaction formally divests Inogen’s U.S. oxygen rental business assets and will result in cash proceeds (up to the stated estimate) being received over time, subject to reconciliation and closing conditions.
• Investors should watch for subsequent filings and disclosures (closing confirmation, final purchase price after reconciliation, details of the product supply agreement, and any effects on revenues or balance sheet presentation) to understand the transaction’s actual financial impact.